Earth Science Tech ETST
OTC ETST
$0.09 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Earth Science Tech (ETST) Non Operating Investment Income (2024 - 2026)

Earth Science Tech's (ETST) quarterly Non Operating Investment Income came in at $365537.0 in Q2 2026, up 170.14% on a YoY basis from $135316.0 in Q2 2025, and up 124.47% quarter-over-quarter from -$1.5 million in Q1 2026.

Analysis

Earth Science Tech (ETST) Non Operating Investment Income (2024 - 2026) Analysis & Trends

Earth Science Tech (ETST) has reported Non Operating Investment Income for 3 consecutive years, with $365537.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non Operating Investment Income rose 170.14% year-over-year to $365537.0; the trailing twelve-month figure through Jun 2026 stood at -$1.5 million (changed N/A YoY), and the FY2026 full-year result was -$957118.0, down 161.75% from the prior year.
  • Non Operating Investment Income advanced to $365537.0 in Q2 2026 per ETST's latest filing, from -$1.5 million in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $365537.0 in Q2 2026 and bottomed at -$1.5 million in Q1 2026.
  • Historically, Non Operating Investment Income has averaged -$250894.1 across 3 years, with a median of -$168384.0 in 2025.
  • The widest YoY moves for Non Operating Investment Income: up 170.14% in 2026, down 787.3% in 2026.
  • Over 3 years, Non Operating Investment Income stood at -$197277.0 in 2024, then tumbled by 211.11% to -$613741.0 in 2025, then soared by 159.56% to $365537.0 in 2026.
  • According to Business Quant data, Non Operating Investment Income over the past three periods registered $365537.0, -$1.5 million, and -$613741.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Teva Pharmaceutical Industries 42.61 Bn 38.95 Bn 2.15 Bn -
2 Viatris 19.18 Bn 18.30 Bn 1.46 Bn -
3 Dr Reddys Laboratories 9.85 Bn 9.68 Bn 396.53 Mn -
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn -
5 Bausch Health Companies 2.36 Bn 518.87 Mn 2.10 Bn -
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -
8 Amphastar Pharmaceuticals 994.21 Mn 704.09 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 405.56 Mn 364.31 Mn 17.15 Mn -
10 Earth Science Tech 25.88 Mn 23.09 Mn 6.28 Mn 365,537.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 365,537.00
Mar 31, 2026 -1.49 Mn
Dec 31, 2025 -613,741.00
Sep 30, 2025 216,359.00
Jun 30, 2025 135,316.00
Mar 31, 2025 -168,384.00
Dec 31, 2024 -197,277.00